Anticorps Polyclonal de lapin anti-PRKAR1A
PRKAR1A Polyclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 20358-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
20358-1-PBS cible PRKAR1A dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | PRKAR1A Protéine recombinante Ag14216 |
| Nom complet | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) |
| Masse moléculaire calculée | 381 aa, 43 kDa |
| Poids moléculaire observé | 43-45 kDa |
| Numéro d’acquisition GenBank | BC036285 |
| Symbole du gène | PRKAR1A |
| Identification du gène (NCBI) | 5573 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
PKA is a heterotetramer inactive kinase composed of two regulatory and two catalytic submits. The regulatory subunits are encoded by four genes (PRKAR1A, PRKAR2A, PRKAR1B, and PRKAR2B). PRKAR1A, a gene coding for the cAMP-dependent protein kinase (PKA) 1α regulatory submit, is located on human chromosome 17q22-24. PRKAR1A protein insufficiency and PKA dysregulation have been implicated in various types of disorders, including Albright hereditary osteodystrophy (AHO), pseudohypoparathyroidism (PHP), acrodysostosis (ACRDYS), and Carney complex. PRKAR1A protein expression level was significantly dysregulated in multiple primary carcinomas and distant metastases, such as cardiac myxomas, odontogenic myxomas, anaplastic thyroid carcinomas, breast cancer, pediatric pituitary adenomas, and Schwann cell tumors.





















